Fragmin (Dalteparin)

Fragmin is a type of blood thinner. It helps prevent blood clots from forming in your veins or arteries. It's often used to treat or prevent conditions like deep vein thrombosis or pulmonary embolism, which are serious blood clots.

Brand names:Fragmin
Medication

What people taking Fragmin (Dalteparin) report

Every report comes from a Lived member, sent anonymously.

Have you tried Fragmin (Dalteparin) for DVT (Deep Vein Thrombosis)?

NameHow it went

About Fragmin (Dalteparin)

What It's For

Dalteparin, sold as Fragmin, is an injected blood thinner (anticoagulant) from a group of medicines called low molecular weight heparins. Its most common use is preventing deep vein thrombosis (DVT), a blood clot in a deep vein, usually in the leg, that can break loose and travel to the lungs as a pulmonary embolism (PE). Fragmin is approved for this after hip replacement surgery, after abdominal surgery in people at risk of clots, and for people whose movement is severely limited during a serious illness. It has three other approved uses. In adults with cancer who develop a DVT or PE, it is given daily for six months to lower the chance of another clot. In children, from newborns born at 35 weeks of pregnancy or later through the teenage years, it treats DVT or PE. And in the hospital, it is given for a few days together with aspirin to people with unstable angina (chest pain that comes on at rest or is getting worse) or a certain type of heart attack, to help prevent further heart damage. Enoxaparin (Lovenox) is a closely related low molecular weight heparin used in many of the same situations.

How It Works

Blood clots form through a chain of clotting proteins that ends with thrombin, the enzyme that builds the clot. Dalteparin is made by breaking heparin, a long-used anticoagulant taken from pig intestine, into smaller pieces. It works by strengthening antithrombin, a natural protein that switches clotting factors off, and it acts mainly on one of them, called factor Xa. With less factor Xa activity, less thrombin is made. The result is that new clots are less likely to form and existing clots are less likely to grow. Dalteparin does not dissolve a clot that is already there; the body breaks that down gradually on its own while the medicine keeps it from getting bigger.

Dosage & Administration

Dalteparin is injected under the skin, usually once a day. Children and people treated in the hospital for heart problems receive it twice a day. It comes in prefilled syringes and in vials. The dose depends on the reason for treatment: clot prevention around surgery or during illness typically uses a fixed dose for about 5 to 14 days, while treating a clot uses a dose based on body weight. For cancer-related clots, the dose is higher in the first month and a little lower for months two through six. Many people learn to inject themselves at home. The injection goes into the fatty tissue in a U-shaped area around the navel, the upper outer thigh or the upper outer buttock, while sitting or lying down, and the site should change each day. When using the belly or thigh, a fold of skin is pinched up during the injection. Dalteparin must never be injected into a muscle. With a fixed-dose prefilled syringe, leave the small air bubble in place, because pushing it out can waste part of the dose. The needle cover on the prefilled syringes may contain natural rubber latex, which matters for anyone with a latex allergy. In severe kidney disease, dalteparin is cleared more slowly, so the care team may check an anti-Xa level (a blood test showing how much of the drug's effect is present) and adjust the dose. Children's doses are set and adjusted the same way.

Side Effects

Bleeding is the main side effect. Bruising, a small lump of collected blood (hematoma) or soreness where the needle went in is common, and small cuts may take longer than usual to stop bleeding. Some people have a temporary rise in liver enzymes on blood tests, which usually causes no symptoms. Tell the care team about unusual bruising, bleeding gums, repeated nosebleeds, or a rash of tiny dark red spots under the skin. The spots can signal a low platelet count; platelets are the blood cells that help seal a wound. Contact the care team right away about signs of internal bleeding, such as red or brown urine, red or black stools, vomiting or coughing up blood, or unexplained dizziness or weakness. Bleeding that is heavy or will not stop, or a significant fall or blow to the head, needs urgent medical evaluation.

Interactions & Warnings

Dalteparin carries a boxed warning from the U.S. Food and Drug Administration (FDA) about spinal procedures. In someone taking it who has spinal or epidural anesthesia, an epidural catheter for pain relief, or a lumbar puncture (spinal tap), bleeding can collect around the spinal cord and press on it, which can cause long-term or permanent paralysis. Tell every surgeon, anesthesiologist and dentist about dalteparin before any procedure so that dose timing can be planned. After such a procedure, new back pain, tingling, numbness or weakness in the legs, or loss of bladder or bowel control needs emergency medical care right away. Other medicines that affect clotting add to the bleeding risk. These include other anticoagulants, antiplatelet medicines such as clopidogrel, clot-dissolving drugs given in the hospital, and NSAIDs (nonsteroidal anti-inflammatory drugs) such as aspirin, ibuprofen and naproxen, including over-the-counter versions. Ask the prescriber before taking any of them, unless they are already part of the plan, as aspirin is in the heart regimen. Dalteparin is not used in people with active major bleeding, a past episode of heparin-induced thrombocytopenia (HIT, an immune reaction to heparin that lowers platelets and can paradoxically cause clots), or an allergy to dalteparin, heparin or pork products. Conditions that raise bleeding risk, such as severe uncontrolled high blood pressure, a recent stomach or bowel bleed, or recent brain, spine or eye surgery, call for extra caution. The multiple-dose vial contains benzyl alcohol, a preservative that can seriously harm newborns and infants, so they receive preservative-free forms. Preservative-free forms are also preferred when dalteparin is needed during pregnancy, where guidelines favor low molecular weight heparins over standard heparin for treating clots. Only small amounts pass into breast milk, and no harm to breastfed babies has been reported.

What to Expect

For surgery or a hospital stay, dalteparin is usually a short course that ends at discharge or soon after. For a clot linked to cancer, the approved course is six months of daily injections. In the trial behind that approval, about 8 percent of people on dalteparin had another clot over six months, compared with about 16 percent of those who switched to warfarin-type pills, with most of the difference in the first month. Use beyond six months has not been studied, so what happens next depends on whether the cancer is still active and on bleeding risk. Daily injections are a real commitment, and cancer guidelines now also recommend apixaban (Eliquis), an oral blood thinner, for many people, so the choice is worth discussing. Adults usually do not need the regular INR (international normalized ratio) clotting tests that warfarin requires. Instead, the care team checks blood counts from time to time, mainly to watch the platelet count and look for hidden blood loss. Do not stop injections early or skip them without talking to the prescriber, since stopping early removes the protection the course is meant to provide.

Questions to Ask Your Doctor

  1. 1.How long will I need dalteparin, and what is the plan when this course ends?
  2. 2.Would a pill such as apixaban, or a different injection, suit me better, and why?
  3. 3.Who will show me how to inject it, and what should I do if I miss a dose?
  4. 4.How should we plan around surgery, dental work or an epidural while I am taking it?
  5. 5.Which pain relievers and supplements are safe for me to use with it?

Last reviewed • Oct 2026

Educational content, not medical advice.